Cardinal Health (NYSE:CAH) Announces FY 2027 Earnings Guidance

Cardinal Health (NYSE:CAH) issued an update on its FY 2027 earnings guidance on Thursday. The company provided earnings per share guidance of 12.400-12.600 for the period, compared to the consensus EPS estimate of 12.560. The company issued revenue guidance of -.

Cardinal Health Trading Down 0.4%

Shares of Cardinal Health stock opened at $223.12 on Thursday. Cardinal Health has a 12-month low of $150.77 and a 12-month high of $258.30. The company has a market cap of $51.66 billion, a P/E ratio of 30.86, a PEG ratio of 1.35 and a beta of 0.51. The company’s fifty day simple moving average is $232.91 and its two-hundred day simple moving average is $219.94.

Cardinal Health (NYSE:CAH) last posted its earnings results on Tuesday, August 11th. The company reported $2.91 EPS for the quarter, topping the consensus estimate of $2.42 by $0.49. The firm had revenue of $63.67 billion during the quarter, compared to analysts’ expectations of $65.15 billion. Cardinal Health had a net margin of 0.67% and a negative return on equity of 98.53%. The company’s quarterly revenue was up 5.8% compared to the same quarter last year. During the same period last year, the company posted $2.08 EPS. Cardinal Health has set its FY 2027 guidance at 12.400-12.600 EPS. Analysts predict that Cardinal Health will post 12.55 EPS for the current fiscal year.

Cardinal Health Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Thursday, October 15th. Investors of record on Thursday, October 1st will be given a dividend of $0.5158 per share. This represents a $2.06 dividend on an annualized basis and a yield of 0.9%. The ex-dividend date of this dividend is Thursday, October 1st. Cardinal Health’s dividend payout ratio (DPR) is 28.49%.

Wall Street Analyst Weigh In

Several equities analysts have recently weighed in on the company. Royal Bank Of Canada began coverage on Cardinal Health in a report on Wednesday, August 19th. They set an “outperform” rating and a $276.00 price target for the company. UBS Group raised their price target on shares of Cardinal Health from $274.00 to $280.00 and gave the company a “buy” rating in a research report on Wednesday, August 12th. Barclays boosted their price objective on shares of Cardinal Health from $258.00 to $275.00 and gave the stock an “overweight” rating in a report on Thursday, August 13th. Leerink Partners set a $292.00 price objective on Cardinal Health in a research report on Tuesday, August 11th. Finally, Weiss Ratings downgraded Cardinal Health from a “buy (b+)” rating to a “buy (b)” rating in a research note on Wednesday, August 19th. Sixteen analysts have rated the stock with a Buy rating and three have given a Hold rating to the stock. According to MarketBeat, the company currently has an average rating of “Moderate Buy” and a consensus price target of $266.56.

Insider Activity at Cardinal Health

In other Cardinal Health news, CEO Deborah Weitzman sold 7,354 shares of the firm’s stock in a transaction dated Tuesday, August 18th. The stock was sold at an average price of $235.45, for a total value of $1,731,499.30. Following the transaction, the chief executive officer directly owned 77,901 shares of the company’s stock, valued at approximately $18,341,790.45. This trade represents a 8.63% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, insider Michelle Greene sold 11,650 shares of the company’s stock in a transaction dated Tuesday, August 18th. The shares were sold at an average price of $235.72, for a total transaction of $2,746,138.00. Following the sale, the insider directly owned 10,330 shares of the company’s stock, valued at $2,434,987.60. The trade was a 53.00% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Insiders have sold 210,271 shares of company stock valued at $49,626,657 over the last quarter. 0.12% of the stock is owned by company insiders.

About Cardinal Health

Cardinal Health, Inc is a healthcare services and products company that supports pharmacies, hospitals, ambulatory surgery centers, physician offices and other healthcare providers. Its operations are primarily organized into Pharmaceutical and Medical segments.

The Pharmaceutical segment distributes branded, generic, specialty and over-the-counter medicines, as well as consumer health products. It also provides services related to specialty pharmaceuticals, pharmaceutical sourcing, nuclear and precision health products, and data and analytics for pharmaceutical manufacturers and healthcare organizations.

The Medical segment distributes medical and surgical products, including gloves, apparel, incontinence supplies, laboratory products and other essential items.